Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 26, 2020 05:19 ET | Source: Verona Pharma plc

Verona Pharma plc: Grant of RADSUs and PDMR Dealings

LONDON and RALEIGH, N.C., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on...
August 24, 2020 02:00 ET | Source: Verona Pharma plc

Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020

LONDON and RALEIGH, N.C., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases,...
August 19, 2020 02:00 ET | Source: Verona Pharma plc

Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD

LONDON and RALEIGH, N.C., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases,...
August 14, 2020 02:00 ET | Source: Verona Pharma plc

Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020

Completed $200 million private placement post period Phase 3 COPD clinical trials planned to start later this year Pilot clinical study in patients hospitalized with COVID-19 planned to...
August 07, 2020 10:46 ET | Source: Verona Pharma plc

Verona Pharma plc: TR-1: Standard form for notification of major holdings

LONDON and RALEIGH, N.C., Aug. 07, 2020 (GLOBE NEWSWIRE) -- NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of...
August 04, 2020 13:13 ET | Source: Verona Pharma plc

Verona Pharma plc: Issue of Equity, PDMR Dealings & Total Voting Rights

LONDON and RALEIGH, N.C., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on...
August 03, 2020 02:00 ET | Source: Verona Pharma plc

Verona Pharma Announces August 2020 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases,...
July 30, 2020 05:51 ET | Source: Verona Pharma plc

Verona Pharma plc: TR-1: Standard form for notification of major holdings

LONDON and RALEIGH, N.C., July 30, 2020 (GLOBE NEWSWIRE) -- NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of...
July 30, 2020 02:00 ET | Source: Verona Pharma plc

Verona Pharma to Announce Interim Results for the Three and Six Months Ended June 30, 2020 and Provide Corporate Update

LONDON and RALEIGH, N.C., July 30, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...
July 27, 2020 02:01 ET | Source: Verona Pharma plc

Verona Pharma plc: TR-1: Standard form for notification of major holdings

LONDON and RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of...